Breath provides a non-invasive easy access to the chemistry of the body.
They have the potential to dramatically ease diagnosis, but identifying biomarkers in breath has been difficult.
Metabolites in breath are very diluted, and mixed with other contaminants previously inhaled. Biologically significant species tend to have very low vapor pressures because they are larger biomolecules. As a result, the technology required to detect them has to provide very high sensitivity, separation capacity, and repeatability.
Condensation may produce strong memory effects, which can deteriorate the limits of detection in for low vapor pressure species. A dedicated breath analyzer must solve these problems, which become more important as the sensitivity is improved.
In addition, identifying a biomarker with statistical confidence requires measuring the breath of a large population of patients and controls. In this respect, the technology must be easy to use so that it can be seamlessly integrated in the normal workflow of the clinical practice.
SUPER SESI brings breath biomarker discovery to the clinical practice.
FIT has addressed the technical problems so that you can easily analyze the breath composition of your patients, and identify relevant biomarkers.